CAS No. 874998-51-3

2-(1H-benzimidazol-2-ylmethyl)-1,2,3,4,6,7,12,12a-octahydropyrazino[1',2':1,6]pyrido[3,4-b]indole

2(1H)-Quinolinone,4-[(2-methoxyethyl)amino]-3-[5-(4-morpholinyl)-1H-benzimidazol-2-yl]-

2(1H)-Quinolinone,4-amino-3-[5-[4-(1-methylethyl)-1-piperazinyl]-1H-benzimidazol-2-yl]-

2-Amino-1-(4-methyl-1-piperazinyl)-1-propanone

1-Piperidinecarboxylic acid, 4-[[(4-aminophenyl)sulfonyl]amino]-,1,1-dimethylethyl ester

2(1H)-Quinolinone,4-amino-3-[5-(4-ethyl-1-piperazinyl)-1H-benzimidazol-2-yl]-1-methyl-

405168-62-9

1-Piperidinecarboxylic acid, 4-[[(2-furanylmethyl)amino]carbonyl]-,1,1-dimethylethyl ester

1-Piperidinecarboxylic acid, 4-[[4-(1-piperidinylmethyl)phenyl]methyl]-,phenylmethyl ester, monohydrochloride

2(1H)-Quinolinone,4-amino-5-methoxy-3-(5-methyl-1H-benzimidazol-2-yl)-

2(1H)-Quinolinone,4-[(3S)-1-azabicyclo[2.2.2]oct-3-ylamino]-3-(1H-benzimidazol-2-yl)-6,7-dimethoxy-

21H,23H-porphine, 5,15-dibutyl-2,3,7,8,12,13,17,18-octamethyl-

2(1H)-Quinolinone,6-chloro-3-ethyl-3,4-dihydro-3-[3-(methylamino)propyl]-1-(4-methylphenyl)-, (2S,3S)-2,3-dihydroxybutanedioate (1:1)

792122-83-9

2(1H)-Quinolinone,6-chloro-1-ethyl-4-[[1-(3-phenyl-2-propenyl)-4-piperidinyl]amino]-

1,3-Dioxolane,4-(chloromethyl)-5-[(4-methoxyphenoxy)methyl]-2,2-dimethyl-, (4S,5R)-

2(1H)-Quinolinone,6-chloro-3-[5-(4-morpholinyl)-1H-benzimidazol-2-yl]-4-[[2-(1-piperidinyl)ethyl]amino]-

1-Piperidinecarboxylic acid, 4-[[6-(trifluoromethyl)-3-pyridinyl]amino]-,1,1-dimethylethyl ester

2(1H)-Quinolinone,4-hydroxy-3-[[4-(1-methyl-1-phenylethyl)-2-nitrophenyl]azo]-

2(1H)-Quinolinone,6-chloro-3-[(4S)-4,5-dihydro-4-(2-methylpropyl)-2-oxazolyl]-4-phenyl-

835882-15-0

Phosphine, 5-hexenyldiphenyl-

2(1H)-Quinolinone,4-hydroxy-3-(7-methyl-1,1-dioxido-2H-pyrido[2,3-e]-1,2,4-thiadiazin-3-yl)-1-(phenylmethyl)-, monosodium salt

Benzoic acid, 4-bromo-, (2Z)-2-tridecenyl ester

2(1H)-Quinolinone,6-chloro-4-phenyl-3-[3-[[[2-(1-pyrrolidinyl)ethyl]amino]methyl]-5-isoxazolyl]-

2(1H)-Quinolinone,4-amino-6-fluoro-3-[5-fluoro-6-(4-morpholinyl)-1H-benzimidazol-2-yl]-

1-Piperidinecarboxylic acid, 4-[2-carboxy-5-(dimethylamino)phenoxy]-,1-(1,1-dimethylethyl) ester

852370-76-4

2(1H)-Quinolinone,4-amino-3-[5-[[2-(1-piperidinyl)ethyl]amino]-1H-benzimidazol-2-yl]-

1-Piperidinecarboxylic acid, 4-[[(2R)-2-amino-2-phenylethoxy]methyl]-,1,1-dimethylethyl ester

[1,2,4]Triazolo[1,5-a]pyrimidine, 6-(2-chlorophenyl)-

2(1H)-Quinolinone,4-amino-3-[5-(4-morpholinyl)-1H-benzimidazol-2-yl]-

2-Butenal, 3-[5-(1-methylethyl)-1-(2,2,2-trifluoroethyl)-1H-pyrazol-3-yl]-,(E)-

2(1H)-Quinolinone,4-[(3R)-1-azabicyclo[2.2.2]oct-3-ylamino]-3-(1H-benzimidazol-2-yl)-6,7-difluoro-

405169-63-3

2(1H)-Quinolinone,5-bromo-3-(1,1-dioxido-2H-1,2,4-benzothiadiazin-3-yl)-4-hydroxy-1-(3-methylbutyl)-

Piperazine, 1-(3-methylphenyl)-4-[(2-methyl-4-thiazolyl)methyl]-,monohydrochloride

1-Piperidinecarboxylic acid, 4-[2-carboxy-5-(methylthio)phenoxy]-,1-(1,1-dimethylethyl) ester

2(1H)-Quinolinone,5-[(1R)-2-[[6-(4-phenylbutoxy)hexyl](phenylmethyl)amino]-1-[(tetrahydro-2H-pyran-2-yl)oxy]ethyl]-8-(phenylmethoxy)-

Tallow, hydrogenated, reaction products with polyethylene

2(1H)-Quinolinone,6-chloro-3-(3-methyl-5-isoxazolyl)-4-(1-naphthalenyl)-

835881-48-6